» Articles » PMID: 18082412

A MicroRNA-based Gene Dysregulation Pathway in Huntington's Disease

Overview
Journal Neurobiol Dis
Specialty Neurology
Date 2007 Dec 18
PMID 18082412
Citations 189
Authors
Affiliations
Soon will be listed here.
Abstract

Huntington's disease (HD) is a dominantly-inherited neurodegenerative disorder which is incurable and ultimately fatal. HD is characterised by widespread mRNA dysregulation, particularly in neurons of the forebrain, by mechanisms which are not fully understood. Such dysregulation has been demonstrated to result, in part, from aberrant nuclear localisation of the transcriptional repressor, REST. Here, we show that expression of a number of neuronal-specific microRNAs is also dysregulated in HD tissues, probably as a result of increased repression by REST. This phenomenon is observed in both murine models of HD and in the brains of human HD sufferers. MicroRNA loss is reflected in increased levels of a number of target messenger RNAs. These data are the first to demonstrate a role for microRNAs in HD, and indicate that the molecular aetiology of HD is reflected in a loss of neuronal identity, caused in part by dysregulation of both transcriptional and post-transcriptional mechanisms.

Citing Articles

MiRNAs as major players in brain health and disease: current knowledge and future perspectives.

Kapplingattu S, Bhattacharya S, Adlakha Y Cell Death Discov. 2025; 11(1):7.

PMID: 39805813 PMC: 11729916. DOI: 10.1038/s41420-024-02283-x.


miR-124 coordinates metabolic regulators acting at early stages of human neurogenesis.

Son G, Na Y, Kim Y, Son J, Clemenson G, Schafer S Commun Biol. 2024; 7(1):1393.

PMID: 39455851 PMC: 11511827. DOI: 10.1038/s42003-024-07089-2.


Beneficial effects of miR-132/212 deficiency in the zQ175 mouse model of Huntington's disease.

Nateghi B, Keraudren R, Boulay G, Bazin M, Goupil C, Canet G Front Neurosci. 2024; 18:1421680.

PMID: 39170678 PMC: 11337869. DOI: 10.3389/fnins.2024.1421680.


Identification of molecular targets and small drug candidates for Huntington's disease via bioinformatics and a network-based screening approach.

Hossain M, Tareq M, Biswas P, Tauhida S, Bibi S, Zilani M J Cell Mol Med. 2024; 28(16):e18588.

PMID: 39153206 PMC: 11330274. DOI: 10.1111/jcmm.18588.


MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review.

Azam H, Rossling R, Geithe C, Khan M, Dinter F, Hanack K Front Mol Neurosci. 2024; 17:1386735.

PMID: 38883980 PMC: 11177777. DOI: 10.3389/fnmol.2024.1386735.